MARKET

PKI

PKI

PerkinElmer
NYSE

Real-time Quotes | Nasdaq Last Sale

121.56
-2.49
-2.01%
After Hours: 121.56 0 0.00% 17:28 03/08 EST
OPEN
124.06
PREV CLOSE
124.05
HIGH
126.39
LOW
121.54
VOLUME
1.18M
TURNOVER
--
52 WEEK HIGH
162.70
52 WEEK LOW
62.91
MARKET CAP
13.62B
P/E (TTM)
18.75
1D
5D
1M
3M
1Y
5Y
News On Oxford Immunotec Global PLC (OXFD) Now Under PKI
News On Oxford Immunotec Global PLC (OXFD) Now Under PKI
Dow Jones · 1h ago
PerkinElmer Inc. stock underperforms Monday when compared to competitors
Shares of PerkinElmer Inc. shed 2.01% to $121.56 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...
marketwatch.com · 1h ago
Fitch Rates Illumina's First-Time IDR 'BBB'; Outlook Stable
reuters.com · 1h ago
8-K: PERKINELMER INC
(EDGAR Online via COMTEX) -- PERKINELMER INC false 0000031791 0000031791 2021-03-08 2021-03-08 0000031791 pki:Commonstock1parvaluepershareMember 2021-03-08...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 1h ago
Global Syringe Filter Market 2020 Overview, Key Players, Segmentation Analysis, Development Status and Forecast by 2025
Mar 08, 2021 (CDN Newswire via Comtex) -- Global Syringe Filter Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 is extremely...
CDN Newswire · 4h ago
Cancer Diagnostics Market Research Report 2021 Elaborate Analysis With Growth Forecast To 2028
Mar 08, 2021 (Heraldkeepers) -- Tumor is a hereditary malady driven by substantial or heritable transformations. Advancement of new DNA sequencing and...
Heraldkeepers · 6h ago
Should You Buy PerkinElmer (PKI) Stock Before It’s Too Late?
Bretton Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 11.52% for the quarter, underperforming its benchmark, the S&P 500 Index which returned 12.15% in the same quarter. You should ch...
Insider Monkey · 6h ago
Press Release: PerkinElmer Adds HPLC Columns to Consumables Portfolio
Dow Jones · 7h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PKI. Analyze the recent business situations of PerkinElmer through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PKI stock price target is 164.50 with a high estimate of 193.00 and a low estimate of 135.00.
EPS
Institutional Holdings
Institutions: 802
Institutional Holdings: 117.20M
% Owned: 104.59%
Shares Outstanding: 112.06M
TypeInstitutionsShares
Increased
197
8.15M
New
142
1.00M
Decreased
189
6.41M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-2.17%
Healthcare Equipment & Supplies
-1.34%
Key Executives
Non-Executive Chairman/Independent Director
Alexis Michas
Non-Executive Chairman/Independent Director
Alexandros Michas
President/Chief Executive Officer/Director
Prahlad Singh
Chief Financial Officer/Senior Vice President
James Mock
Chief Human Resource Officer/Senior Vice President
Deborah Butters
Senior Vice President/General Counsel/Secretary
Joel Goldberg
Senior Vice President
Daniel Tereau
Senior Vice President
Tajinder Vohra
Vice President/Chief Accounting Officer
Andrew Okun
Independent Director
Peter Barrett
Independent Director
Samuel Chapin
Independent Director
Sylvie Gregoire
Independent Director
Michel Vounatsos
Independent Director
Frank Witney
Independent Director
Pascale Witz
Independent Director
Franklin Witney
Declaration Date
Dividend Per Share
Ex-Div Date
01/28/2021
Dividend USD 0.07
04/15/2021
10/22/2020
Dividend USD 0.07
01/21/2021
07/23/2020
Dividend USD 0.07
10/15/2020
04/30/2020
Dividend USD 0.07
07/16/2020
01/23/2020
Dividend USD 0.07
04/16/2020
10/24/2019
Dividend USD 0.07
01/16/2020
07/25/2019
Dividend USD 0.07
10/17/2019
04/25/2019
Dividend USD 0.07
07/18/2019
01/24/2019
Dividend USD 0.07
04/17/2019
10/24/2018
Dividend USD 0.07
01/17/2019
07/23/2018
Dividend USD 0.07
10/18/2018
04/26/2018
Dividend USD 0.07
07/19/2018
01/25/2018
Dividend USD 0.07
04/12/2018
10/27/2017
Dividend USD 0.07
01/18/2018
07/25/2017
Dividend USD 0.07
10/19/2017
05/01/2017
Dividend USD 0.07
07/19/2017
01/27/2017
Dividend USD 0.07
04/11/2017
10/27/2016
Dividend USD 0.07
01/18/2017
07/28/2016
Dividend USD 0.07
10/12/2016
04/26/2016
Dividend USD 0.07
07/13/2016
01/29/2016
Dividend USD 0.07
04/13/2016
10/30/2015
Dividend USD 0.07
01/13/2016
07/24/2015
Dividend USD 0.07
10/14/2015
04/28/2015
Dividend USD 0.07
07/15/2015
03/18/2015
Dividend USD 0.07
04/15/2015
10/24/2014
Dividend USD 0.07
01/14/2015
07/25/2014
Dividend USD 0.07
10/15/2014
04/22/2014
Dividend USD 0.07
07/16/2014
01/24/2014
Dividend USD 0.07
04/15/2014
10/25/2013
Dividend USD 0.07
01/15/2014
07/29/2013
Dividend USD 0.07
10/16/2013
About PKI
PerkinElmer Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. Its Discovery & Analytical Solutions segment serves the life sciences and applied markets. Through the Diagnostics Segment, it offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals. It provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its product under various brands, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, FragilEase, Genoglyphix, GSP, PG-Seq, PG-Find, Protein Clear, ProteinEXact and QSight, Glutomatic, Honigs Regression, HyperDSC, Inframatic, LAMBDA, NexION, NEN, OneSource, Opera Phenix, Operetta CLS and OsteoSense.

Webull offers kinds of PerkinElmer, Inc. stock information, including NYSE:PKI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PKI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PKI stock methods without spending real money on the virtual paper trading platform.